#USA #Boston #Spectra Medical #Elevaris Medical #Precision Technologies

Elevaris Medical Devices: A New Era of Precision in Healthcare

In a major development in the medical devices sector, Spectra Medical Devices and XL Precision Technologies have officially merged their brands to form Elevaris Medical Devices. This transition not only represents a merger of two highly reputable entities but aims to create a unified force in the realm of contract development and manufacturing of precision medical devices. The announcement made on January 28, 2025, signifies the beginning of a transformative chapter in medical technology.

The acquisition of XL Precision Technologies by Spectra Medical is noteworthy and was facilitated by QHP Capital, an investment group focused on health technologies and services, announced in September 2024. This strategic move allows both companies to pool their strengths and deliver unprecedented services tailored for medical device manufacturers, ranging from well-established original equipment manufacturers (OEMs) to emerging startups. Spectra has built a solid reputation for its extensive engineering and manufacturing capabilities, paired with dedicated customer support that has been a hallmark of their service. Conversely, XLPT has earned accolades for its finesse in manufacturing microcomponents, complex tubular parts, and intricate sub-assemblies.

The creation of Elevaris Medical Devices not only preserves the legacy of both organizations but also embodies their shared vision of delivering unparalleled expertise and a collaborative approach. Richard Zrebiec, CEO of Elevaris Medical Devices, stated, “The acquisition enabled us to join forces with a partner we have long trusted. A unified brand illustrates our collective commitment to client success.”

As Elevaris Medical Devices, the company aims to deliver exceptional value through its unmatched capabilities. The integrated team, composed of experts in engineering, design, and development, is determined to leverage their deep-rooted knowledge and strategic insight to generate groundbreaking solutions. Zrebiec emphasized, “From concept to design through to manufacturing, we are uniquely positioned to assist our clients in developing next-generation medical devices that will benefit healthcare institutions and enhance global health outcomes.”

Elevaris Medical Devices is poised to be the go-to partner for advancing precision medical device development and manufacturing. The company serves a variety of clients, including multinational health enterprises, leading global OEMs, and emerging technology firms. Furthermore, Elevaris specializes in creating custom procedure needles along with producing precision microcomponents, complex tubular parts, and surgical instruments, thereby reinforcing its position as a leader in the medical device arena.

With over 300 employees across North America, the UK, and South Korea, Elevaris Medical Devices is not just committed to advancing medical technology but also dedicated to expanding its impact worldwide. The merger reflects a promise to uphold excellence while showcasing best practices derived from both original brands. By focusing on a singular vision, Elevaris Medical Devices is set to elevate client outcomes to new heights, fostering the industry’s innovation and commitment to healthcare quality.

As the medical landscape continues to evolve, Elevaris is determined to play a pivotal role in shaping the future of healthcare through technology. Their advanced manufacturing capabilities ensure that Elevaris Medical Devices stands at the forefront of medical innovation, prepared to meet the challenges of tomorrow’s healthcare environment.

For further details about Elevaris Medical Devices, visit their website at elevarismedical.com.